Apogee Therapeutics(APGE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

APGE Apogee Therapeutics

未开盘 03-05 16:00:00 EST

70.92

-1.39

-1.92%

盘后70.97

+0.05+0.07%

16:57 EST

最高72.92	最低68.78	成交量111.93万
今开71.19	昨收72.31	日振幅5.73%
总市值49.28亿	流通市值37.20亿	总股本6,949万
成交额7,885万	换手率2.13%	流通股本5,245万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"APGE","market":"US","secType":"STK","nameCN":"Apogee Therapeutics","latestPrice":70.92,"timestamp":1772744400000,"preClose":72.31,"halted":0,"volume":1119262,"hourTrading":{"tag":"盘后","latestPrice":70.97,"preClose":70.92,"latestTime":"16:57 EST","volume":15593,"amount":1105878.3498,"timestamp":1772747870945,"change":0.05,"changeRate":0.000705,"amplitude":0.000705},"delay":0,"changeRate":-0.019222790761996966,"floatShares":52454900,"shares":69485247,"eps":-4.215513,"marketStatus":"未开盘","change":-1.39,"latestTime":"03-05 16:00:00 EST","open":71.19,"high":72.92,"low":68.775,"amount":78850306.62176,"amplitude":0.057323,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.215513,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1772787600000},"marketStatusCode":0,"adr":0,"listingDate":1689307200000,"exchange":"NASDAQ","adjPreClose":72.31,"preHourTrading":{"tag":"盘前","latestPrice":71.9,"preClose":72.31,"latestTime":"09:29 EST","volume":6805,"amount":492245.3912,"timestamp":1772720944261,"change":-0.41,"changeRate":-0.00567,"amplitude":0.035956},"postHourTrading":{"tag":"盘后","latestPrice":70.97,"preClose":70.92,"latestTime":"16:57 EST","volume":15593,"amount":1105878.3498,"timestamp":1772747870945,"change":0.05,"changeRate":0.000705,"amplitude":0.000705},"volumeRatio":1.141471,"impliedVol":1.0438,"impliedVolPercentile":0.8486},"requestUrl":"/m/hq/s/APGE","defaultTab":"news","newsList":[{"id":"1160404547","title":"Apogee Therapeutics公布潜在同类最佳抗IL-13抗体Zumilokibart（APG777）治疗轻中度哮喘患者的1B期试验积极中期结果，并展望2026年里程碑与前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1160404547","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160404547?lang=zh_cn&edition=full","pubTime":"2026-01-06 19:00","pubTimestamp":1767697219,"startTime":"0","endTime":"0","summary":"生物制药公司Apogee Therapeutics近日披露了其核心候选药物Zumilokibart（研发代号APG777）在轻中度哮喘患者中开展的1B期临床试验的中期分析数据，结果显示出积极信号。该抗体药物靶向IL-13通路，被公司定位为潜在“同类最佳”疗法。\n与此同时，Apogee还明确了2026年的关键研发节点与战略展望，为后续临床推进和商业化布局奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","APGE","BK4139"],"gpt_icon":0},{"id":"1132494108","title":"Apogee Therapeutics将于2026年1月6日召开电话会议 公布Apg777针对轻中度哮喘患者的1B期临床试验中期结果及2026年预期里程碑","url":"https://stock-news.laohu8.com/highlight/detail?id=1132494108","media":"美股速递","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132494108?lang=zh_cn&edition=full","pubTime":"2026-01-06 05:03","pubTimestamp":1767646992,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics宣布，公司计划于2026年1月6日举行专题电话会议，重点披露其候选药物Apg777在轻中度哮喘患者中开展的1B期临床试验的中期研究数据。此次会议还将详细阐述公司为2026年规划的关键发展节点与战略目标。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APGE","BK4139","LU0053671581.USD"],"gpt_icon":0},{"id":"1155341144","title":"Apogee Therapeutics公布Apg333健康志愿者试验的积极中期一期结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1155341144","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155341144?lang=zh_cn&edition=full","pubTime":"2025-11-10 20:01","pubTimestamp":1762776080,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics公布Apg333健康志愿者试验的积极中期一期结果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APGE","BK4139"],"gpt_icon":0},{"id":"1183254046","title":"Apogee Therapeutics盘前股价下跌6.4%，此前公司宣布3亿美元承销公开发行普通股定价","url":"https://stock-news.laohu8.com/highlight/detail?id=1183254046","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183254046?lang=zh_cn&edition=full","pubTime":"2025-10-09 19:36","pubTimestamp":1760009780,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics股价在盘前交易中下跌6.4%，此前该公司宣布了3亿美元承销公开发行普通股的定价消息。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APGE"],"gpt_icon":0},{"id":"1161515124","title":"Apogee Therapeutics宣布公开发行计划后 盘后股价下跌4%至45.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1161515124","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161515124?lang=zh_cn&edition=full","pubTime":"2025-10-09 04:11","pubTimestamp":1759954297,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics在宣布公开发行计划后，盘后交易中股价下跌4%，跌至45.16美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APGE"],"gpt_icon":0},{"id":"2516672751","title":"Apogee Therapeutics, Inc.盘中异动 快速下挫5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516672751","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516672751?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:43","pubTimestamp":1741099438,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时43分，Apogee Therapeutics, Inc.股票出现异动，股价快速下跌5.11%。Apogee Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。Apogee Therapeutics, Inc.公司简介：Apogee Therapeutics Inc 是一家生物技术公司，寻求开发用于治疗特应性皮炎，慢性阻塞性肺疾病和相关炎症和免疫学(I&I)适应症的差异化生物制剂，具有高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503042243589639487e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503042243589639487e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","APGE"],"gpt_icon":0},{"id":"2516634640","title":"Apogee Therapeutics, Inc.盘中异动 大幅拉升6.55%报33.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516634640","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516634640?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:32","pubTimestamp":1741012320,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时32分，Apogee Therapeutics, Inc.股票出现异动，股价大幅上涨6.55%。Apogee Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Apogee Therapeutics, Inc.公司简介：Apogee Therapeutics Inc 是一家生物技术公司，寻求开发用于治疗特应性皮炎，慢性阻塞性肺疾病和相关炎症和免疫学(I&I)适应症的差异化生物制剂，具有高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223201a25d3fdf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223201a25d3fdf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APGE","LENZ"],"gpt_icon":0},{"id":"2514641378","title":"Apogee Therapeutics, Inc.盘中异动 急速下跌5.01%报31.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514641378","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514641378?lang=zh_cn&edition=full","pubTime":"2025-02-27 03:41","pubTimestamp":1740598896,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日03时41分，Apogee Therapeutics, Inc.股票出现波动，股价急速下跌5.01%。Apogee Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.48%。Apogee Therapeutics, Inc.公司简介：Apogee Therapeutics Inc 是一家生物技术公司，寻求开发用于治疗特应性皮炎，慢性阻塞性肺疾病和相关炎症和免疫学(I&I)适应症的差异化生物制剂，具有高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227034136abde309f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227034136abde309f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APGE","BK4139","LENZ"],"gpt_icon":0},{"id":"2512131487","title":"Apogee Therapeutics, Inc.盘中异动 大幅下挫5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512131487","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512131487?lang=zh_cn&edition=full","pubTime":"2025-02-20 01:06","pubTimestamp":1739984795,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日01时06分，Apogee Therapeutics, Inc.股票出现波动，股价大幅下跌5.10%。Apogee Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。Apogee Therapeutics, Inc.公司简介：Apogee Therapeutics Inc 是一家生物技术公司，寻求开发用于治疗特应性皮炎，慢性阻塞性肺疾病和相关炎症和免疫学(I&I)适应症的差异化生物制剂，具有高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220010635abd51c2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220010635abd51c2c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APGE","LENZ"],"gpt_icon":0},{"id":"2512191628","title":"Apogee Therapeutics, Inc.盘中异动 急速下跌5.15%报34.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512191628","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512191628?lang=zh_cn&edition=full","pubTime":"2025-02-19 04:11","pubTimestamp":1739909474,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日04时11分，Apogee Therapeutics, Inc.股票出现波动，股价快速下跌5.15%。Apogee Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.64%。Apogee Therapeutics, Inc.公司简介：Apogee Therapeutics Inc 是一家生物技术公司，寻求开发用于治疗特应性皮炎，慢性阻塞性肺疾病和相关炎症和免疫学(I&I)适应症的差异化生物制剂，具有高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190411149627cd99&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190411149627cd99&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APGE","LENZ"],"gpt_icon":0},{"id":"2510872093","title":"Apogee Therapeutics, Inc.盘中异动 股价大跌5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510872093","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510872093?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:40","pubTimestamp":1739284844,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时40分，Apogee Therapeutics, Inc.股票出现波动，股价快速下跌5.24%。Apogee Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.31%。Apogee Therapeutics, Inc.公司简介：Apogee Therapeutics Inc 是一家生物技术公司，寻求开发用于治疗特应性皮炎，慢性阻塞性肺疾病和相关炎症和免疫学(I&I)适应症的差异化生物制剂，具有高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112240459881bef2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112240459881bef2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APGE","LENZ"],"gpt_icon":0},{"id":"2509720466","title":"Apogee Therapeutics, Inc.盘中异动 下午盘急速下挫5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509720466","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509720466?lang=zh_cn&edition=full","pubTime":"2025-02-08 02:43","pubTimestamp":1738953817,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日02时43分，Apogee Therapeutics, Inc.股票出现波动，股价急速下跌5.16%。Apogee Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.66%。Apogee Therapeutics, Inc.公司简介：Apogee Therapeutics Inc 是一家生物技术公司，寻求开发用于治疗特应性皮炎，慢性阻塞性肺疾病和相关炎症和免疫学(I&I)适应症的差异化生物制剂，具有高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208024337a23d57ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208024337a23d57ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","APGE","BK4139"],"gpt_icon":0},{"id":"2507513678","title":"Apogee Therapeutics, Inc.盘中异动 早盘股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507513678","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507513678?lang=zh_cn&edition=full","pubTime":"2025-01-31 00:04","pubTimestamp":1738253058,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日00时04分，Apogee Therapeutics, Inc.股票出现波动，股价大幅拉升5.01%。Apogee Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。Apogee Therapeutics, Inc.公司简介：Apogee Therapeutics Inc 是一家生物技术公司，寻求开发用于治疗特应性皮炎，慢性阻塞性肺疾病和相关炎症和免疫学(I&I)适应症的差异化生物制剂，具有高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501310004199876bc94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501310004199876bc94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","APGE","BK4139"],"gpt_icon":0},{"id":"2505272884","title":"Apogee Therapeutics, Inc.盘中异动 早盘急速上涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505272884","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505272884?lang=zh_cn&edition=full","pubTime":"2025-01-21 22:52","pubTimestamp":1737471175,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日22时52分，Apogee Therapeutics, Inc.股票出现异动，股价快速上涨5.26%。Apogee Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.13%。Apogee Therapeutics, Inc.公司简介：Apogee Therapeutics Inc 是一家生物技术公司，寻求开发用于治疗特应性皮炎，慢性阻塞性肺疾病和相关炎症和免疫学(I&I)适应症的差异化生物制剂，具有高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121225255960bbde4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121225255960bbde4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APGE","LENZ"],"gpt_icon":0},{"id":"2503192379","title":"Apogee Therapeutics, Inc.盘中异动 早盘股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503192379","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503192379?lang=zh_cn&edition=full","pubTime":"2025-01-16 23:37","pubTimestamp":1737041826,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日23时37分，Apogee Therapeutics, Inc.股票出现波动，股价大幅下挫5.07%。Apogee Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.58%。Apogee Therapeutics, Inc.公司简介：Apogee Therapeutics Inc 是一家生物技术公司，寻求开发用于治疗特应性皮炎，慢性阻塞性肺疾病和相关炎症和免疫学(I&I)适应症的差异化生物制剂，具有高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011623370698689a7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011623370698689a7f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","APGE"],"gpt_icon":0},{"id":"2503647417","title":"Apogee Therapeutics, Inc.盘中异动 早盘急速上涨7.22%报42.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503647417","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503647417?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:31","pubTimestamp":1736951468,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时31分，Apogee Therapeutics, Inc.股票出现波动，股价快速上涨7.22%。Apogee Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.68%。Apogee Therapeutics, Inc.公司简介：Apogee Therapeutics Inc 是一家生物技术公司，寻求开发用于治疗特应性皮炎，慢性阻塞性肺疾病和相关炎症和免疫学(I&I)适应症的差异化生物制剂，具有高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223108a222fd7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115223108a222fd7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APGE","LENZ"],"gpt_icon":0},{"id":"2503547583","title":"Apogee Therapeutics, Inc.盘中异动 早盘快速下跌5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503547583","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503547583?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:39","pubTimestamp":1736779198,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时39分，Apogee Therapeutics, Inc.股票出现波动，股价大幅跳水5.41%。Apogee Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.22%。Apogee Therapeutics, Inc.公司简介：Apogee Therapeutics Inc 是一家生物技术公司，寻求开发用于治疗特应性皮炎，慢性阻塞性肺疾病和相关炎症和免疫学(I&I)适应症的差异化生物制剂，具有高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223958960254d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223958960254d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","APGE","BK4139"],"gpt_icon":0},{"id":"2502867368","title":"Apogee Therapeutics, Inc.盘中异动 早盘股价大跌5.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502867368","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502867368?lang=zh_cn&edition=full","pubTime":"2025-01-10 22:43","pubTimestamp":1736520188,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日22时43分，Apogee Therapeutics, Inc.股票出现波动，股价快速跳水5.82%。Apogee Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.79%。Apogee Therapeutics, Inc.公司简介：Apogee Therapeutics Inc 是一家生物技术公司，寻求开发用于治疗特应性皮炎，慢性阻塞性肺疾病和相关炎症和免疫学(I&I)适应症的差异化生物制剂，具有高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501102243089861eb57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501102243089861eb57&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APGE","BK4139","LENZ"],"gpt_icon":0},{"id":"2495523281","title":"Apogee Therapeutics, Inc.盘中异动 快速跳水5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2495523281","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495523281?lang=zh_cn&edition=full","pubTime":"2024-12-30 22:38","pubTimestamp":1735569520,"startTime":"0","endTime":"0","summary":"北京时间2024年12月30日22时38分，Apogee Therapeutics, Inc.股票出现异动，股价急速下挫5.41%。Apogee Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.86%。Apogee Therapeutics, Inc.公司简介：Apogee Therapeutics Inc 是一家生物技术公司，寻求开发用于治疗特应性皮炎，慢性阻塞性肺疾病和相关炎症和免疫学(I&I)适应症的差异化生物制剂，具有高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241230223840a20f2d05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241230223840a20f2d05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","APGE","BK4139"],"gpt_icon":0},{"id":"2492159313","title":"Apogee Therapeutics, Inc.盘中异动 股价大跌5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492159313","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492159313?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:08","pubTimestamp":1734552483,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时08分，Apogee Therapeutics, Inc.股票出现波动，股价急速跳水5.28%。Apogee Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.00%。Apogee Therapeutics, Inc.公司简介：Apogee Therapeutics Inc 是一家生物技术公司，寻求开发用于治疗特应性皮炎，慢性阻塞性肺疾病和相关炎症和免疫学(I&I)适应症的差异化生物制剂，具有高度未满足的需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219040803984cb7d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219040803984cb7d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APGE","LENZ","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.apogeetherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0265},{"period":"1month","weight":0.0295},{"period":"3month","weight":-0.076},{"period":"6month","weight":0.8727},{"period":"1year","weight":1.2564},{"period":"ytd","weight":-0.0604}],"compareEarnings":[{"period":"1week","weight":-0.0116},{"period":"1month","weight":-0.0119},{"period":"3month","weight":-0.0064},{"period":"6month","weight":0.0526},{"period":"1year","weight":0.1685},{"period":"ytd","weight":-0.0009}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Apogee Therapeutics, Inc.于2023年6月9日作为一家特拉华州公司成立，与此次发行有关，作为一家控股公司，将全资拥有Apogee Therapeutics，LLC，并间接拥有其子公司。该公司是一家生物技术公司，致力于开发用于治疗特应性皮炎、慢性阻塞性肺病及相关炎症和免疫学适应症的差异化生物制剂，这些适应症的需求尚未得到满足。该公司的抗体项目旨在克服现有疗法的局限性，针对的是成熟的作用机制，并结合先进的抗体工程来优化半衰期。","exchange":"NASDAQ","name":"Apogee Therapeutics","nameEN":"Apogee Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Apogee Therapeutics(APGE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Apogee Therapeutics(APGE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Apogee Therapeutics,APGE,Apogee Therapeutics股票,Apogee Therapeutics股票老虎,Apogee Therapeutics股票老虎国际,Apogee Therapeutics行情,Apogee Therapeutics股票行情,Apogee Therapeutics股价,Apogee Therapeutics股市,Apogee Therapeutics股票价格,Apogee Therapeutics股票交易,Apogee Therapeutics股票购买,Apogee Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Apogee Therapeutics(APGE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Apogee Therapeutics(APGE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}